FOUSE JACQUALYN A
SEC CIK 1405288 · EDGAR
BoughtSold
Most active insiders at AGIO, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Goff Brian | CEO, Dir | — | $1.69M |
| 2 | Gheuens Sarah | Chief Medical Off | — | $1.63M |
| 3 | Jones Cecilia | CFO | — | $468.5K |
| 4 | Milanova Tsveta | Chief Commercial Off | — | $353.3K |
| 5 | Burns James William | CLO | — | $344.4K |
| 6 | Washburn Theodore James Jr. | Principal Accounting Off | — | $216.6K |
| 7 | Viswanadhan Krishnan | Chief Corp Dev, Strategy | — | $185.0K |
| 8 | Scadden David | Dir | — | $25.0K |
| 9 | Owen Adams Catherine | Dir | — | — |
| 10 | Ballal Rahul D. | Dir | — | — |
| 14 | FOUSE JACQUALYN A | Dir | — | — |
Transactions 36
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-23 17:22 | 2026-06-18 | AGIO | AGIOS PHARMACEUTICALS, INC. | FOUSE JACQUALYN A | Dir | M - OptEx | $0.00 | +2,816 | 154.2K | +2% | $0 |
| D | 2026-06-18 16:19 | 2026-06-17 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | FOUSE JACQUALYN A | Dir | A - Grant | $0.00 | +454 | 1,551 | +41% | $0 |
| D | 2026-06-10 16:07 | 2026-06-08 | INCY | Incyte | FOUSE JACQUALYN A | Dir | A - Grant | $0.00 | +1,642 | 21.0K | +8% | $0 |
| D | 2025-06-24 | 2025-06-20 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | FOUSE JACQUALYN A | Dir | A - Grant | $0.00 | +203 | 1,097 | +23% | $0 |
| D | 2025-06-23 | 2025-06-20 | AGIO | AGIOS PHARMACEUTICALS, INC. | FOUSE JACQUALYN A | Dir | M - OptEx | $0.00 | +2,120 | 151.3K | +1% | $0 |
| D | 2025-06-12 | 2025-06-10 | INCY | Incyte | FOUSE JACQUALYN A | Dir | A - Grant | $0.00 | +2,518 | 19.3K | +15% | $0 |
| D | 2025-04-10 | 2025-04-10 | AGIO | AGIOS PHARMACEUTICALS, INC. | FOUSE JACQUALYN A | Dir | S - Sale+OE | $25.90 | -7,497 | 149.2K | -5% | -$194.2K |
| D | 2025-04-10 | 2025-04-08 | AGIO | AGIOS PHARMACEUTICALS, INC. | FOUSE JACQUALYN A | Dir | M - OptEx | $0.00 | +15.9K | 156.7K | +11% | $0 |
| D | 2025-03-12 | 2025-03-10 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | FOUSE JACQUALYN A | Dir | A - Grant | $0.00 | +894 | 894 | New | $0 |
| D | 2024-06-17 | 2024-06-13 | AGIO | AGIOS PHARMACEUTICALS, INC. | FOUSE JACQUALYN A | Dir | M - OptEx | $0.00 | +3,388 | 140.8K | +2% | $0 |
| D | 2024-06-14 | 2024-06-12 | INCY | Incyte | FOUSE JACQUALYN A | Dir | A - Grant | $0.00 | +2,830 | 16.8K | +20% | $0 |
| D | 2024-04-10 | 2024-04-10 | AGIO | AGIOS PHARMACEUTICALS, INC. | FOUSE JACQUALYN A | Dir | S - Sale+OE | $27.55 | -7,791 | 137.4K | -5% | -$214.6K |
| D | 2024-04-10 | 2024-04-08 | AGIO | AGIOS PHARMACEUTICALS, INC. | FOUSE JACQUALYN A | Dir | M - OptEx | $0.00 | +15.9K | 145.2K | +12% | $0 |
| D | 2024-01-24 | 2024-01-20 | AGIO | AGIOS PHARMACEUTICALS, INC. | FOUSE JACQUALYN A | Dir | M - OptEx | $0.00 | +23.9K | 140.0K | +21% | $0 |
| D | 2024-01-24 | 2024-01-24 | AGIO | AGIOS PHARMACEUTICALS, INC. | FOUSE JACQUALYN A | Dir | S - Sale+OE | $21.64 | -10.7K | 129.3K | -8% | -$232.0K |
| D | 2024-01-09 | 2024-01-09 | AGIO | AGIOS PHARMACEUTICALS, INC. | FOUSE JACQUALYN A | Dir | S - Sale+OE | $22.99 | -8,391 | 116.1K | -7% | -$192.9K |
| D | 2024-01-09 | 2024-01-05 | AGIO | AGIOS PHARMACEUTICALS, INC. | FOUSE JACQUALYN A | Dir | M - OptEx | $0.00 | +17.5K | 124.5K | +16% | $0 |
| D | 2023-06-30 | 2023-06-30 | AGIO | AGIOS PHARMACEUTICALS, INC. | FOUSE JACQUALYN A | Dir | S - Sale+OE | $28.36 | -10.7K | 107.0K | -9% | -$304.0K |
| D | 2023-06-30 | 2023-06-28 | AGIO | AGIOS PHARMACEUTICALS, INC. | FOUSE JACQUALYN A | Dir | M - OptEx | $0.00 | +23.9K | 117.7K | +25% | $0 |
| D | 2023-06-16 | 2023-06-14 | INCY | Incyte | FOUSE JACQUALYN A | Dir | A - Grant | $0.00 | +2,505 | 14.0K | +22% | $0 |
| D | 2023-04-12 | 2023-04-12 | AGIO | AGIOS PHARMACEUTICALS, INC. | FOUSE JACQUALYN A | Dir | F - Tax | $21.35 | -4,731 | 93.8K | -5% | -$101.0K |
| D | 2023-04-12 | 2023-04-08 | AGIO | AGIOS PHARMACEUTICALS, INC. | FOUSE JACQUALYN A | Dir | M - OptEx | $0.00 | +15.9K | 98.5K | +19% | $0 |
| D | 2023-02-16 | 2023-02-14 | AGIO | AGIOS PHARMACEUTICALS, INC. | FOUSE JACQUALYN A | Dir | M - OptEx | $0.00 | +11.3K | 86.2K | +15% | $0 |
| D | 2023-02-16 | 2023-02-16 | AGIO | AGIOS PHARMACEUTICALS, INC. | FOUSE JACQUALYN A | Dir | F - Tax | $28.91 | -3,648 | 82.6K | -4% | -$105.5K |
| 2023-01-04 | 2022-12-30 | INCY | Incyte | FOUSE JACQUALYN A | Dir | A - Grant | $80.32 | +252 | 11.5K | +2% | +$20.2K | |
| 2022-10-04 | 2022-09-30 | INCY | Incyte | FOUSE JACQUALYN A | Dir | A - Grant | $66.64 | +291 | 11.2K | +3% | +$19.4K | |
| 2022-07-01 | 2022-06-30 | INCY | Incyte | FOUSE JACQUALYN A | Dir | A - Grant | $75.97 | +275 | 10.9K | +3% | +$20.9K | |
| D | 2022-06-17 | 2022-06-15 | INCY | Incyte | FOUSE JACQUALYN A | Dir | A - Grant | $0.00 | +2,144 | 10.7K | +25% | $0 |
| 2022-04-04 | 2022-03-31 | INCY | Incyte | FOUSE JACQUALYN A | Dir | A - Grant | $79.42 | +280 | 8,511 | +3% | +$22.2K | |
| D | 2022-02-23 | 2022-02-18 | AGIO | AGIOS PHARMACEUTICALS, INC. | FOUSE JACQUALYN A | CEO, Dir | M - OptEx | $0.00 | +12.4K | 78.6K | +19% | $0 |
| D | 2022-02-23 | 2022-02-22 | AGIO | AGIOS PHARMACEUTICALS, INC. | FOUSE JACQUALYN A | CEO, Dir | F - Tax | $29.08 | -3,674 | 74.9K | -5% | -$106.8K |
| D | 2022-02-16 | 2022-02-14 | AGIO | AGIOS PHARMACEUTICALS, INC. | FOUSE JACQUALYN A | CEO, Dir | M - OptEx | $0.00 | +11.3K | 69.7K | +19% | $0 |
| D | 2022-02-16 | 2022-02-14 | AGIO | AGIOS PHARMACEUTICALS, INC. | FOUSE JACQUALYN A | CEO, Dir | F - Tax | $30.50 | -3,505 | 66.2K | -5% | -$106.9K |
| 2022-01-04 | 2021-12-31 | INCY | Incyte | FOUSE JACQUALYN A | Dir | A - Grant | $73.40 | +289 | 8,231 | +4% | +$21.2K | |
| 2021-10-04 | 2021-09-30 | INCY | Incyte | FOUSE JACQUALYN A | Dir | A - Grant | $68.78 | +271 | 7,942 | +4% | +$18.6K | |
| 2021-07-02 | 2021-06-30 | INCY | Incyte | FOUSE JACQUALYN A | Dir | A - Grant | $84.13 | +238 | 7,671 | +3% | +$20.0K |
Purchase Sale Sale after option exercise All abbreviations